Betta Pharmaceuticals Co.,Ltd.’s Net Profit Dropped 59.4% in First Half of 2022

Betta Pharmaceuticals Co.,Ltd. (贝达药业股份有限公司) (300558.SZ) reported a net profit of 86.3 million yuan in the first half of 2022, down 59.4% year-on-year.

Meanwhile, the company posted 1.3 billion yuan in revenue, up 8.5% year-on-year.

At the end of the reporting period, it had 7.2 billion yuan in total assets and 2.4 billion yuan in total liabilities, with a liability-to-asset ratio of 33.3%.